Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension

• প্রধান লেখক: O. B. Kuzmin (লেখক), N. V. Buchneva (লেখক), V. V. Belyanin (লেখক), V. V. Zhezha (লেখক), M. V. Stolbova (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Столичная издательская компания, 2024-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Resistant arterial hypertension is characterized by failure to control target blood pressure despite long-term use of optimal or maximum tolerated doses of three different antihypertensive drugs, including diuretic. Patients with resistant hypertension are included in a group of people at high risk...